Pre Course Knowledge Test
CME Accreditation Information
Introduction
Establishing diagnosis and treatment pathways for HCC within a multidisciplinary team
Integrating follow-up HCC care, patient engagement, and clinical collaboration
Interdisciplinary teamwork in transplant evaluation and the critical role of IR clinics in coordinated care
Optimizing HCC referral pathways in community settings
Handling patient HCC treatment schedules and integrating transplant considerations
The importance of patient navigators, and strategies for improving HCC care
Immunotherapy mechanism of action and key clinical trials in advanced HCC
HIMALAYA trial outcomes, survival data, dosing regimen, and immunotherapy combination strategies
CheckMate 9DW trial results, survival curves, dosing, and etiology impacts for HCC immunotherapy treatments
Advanced HCC trial populations, real-world liver function, and criteria for administering immunotherapy
Immunotherapy issues, including hepatitis and pneumonitis, and the effectiveness of combination treatments in HCC care
Combination locoregional therapies and systemic therapies and their impacts on patient outcomes
Optimal timing and dosing strategies for combining Y90 radioembolization with immunotherapy in cancer treatment
BCLC guidelines_ focusing on performance status, liver function, and treatment options for HCC patients
ALBI score, LFT-s, and treatment strategies for HCC
Response intervals and therapeutic approaches for systemic and liver-directed cancer treatments in complex cases
When to use systemic vs liver-directed therapy, performance status, multidisciplinary care, and patient autonomy
The challenges of differing medical opinions in HCC cancer
Impacts of combinatorial approaches and treatment sequence in HCC care
Post Course Knowledge Test
Claim your CME credits here
